FDA Recalls TRP Natural Eyes Sterile Eye Drops for Lack of Sterility
The FDA is recalling TRP Natural Eyes Pink Eye Relief eye drops due to lack of assurance of sterility. The product was distributed to accounts in Rhode Island and Colorado.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. Classified as High under the rubric as a risk-of-harm product—non-sterile eye drops pose potential infection risk—where actual injury has not yet been documented.
Plain-English summary
TRP Natural Eyes Pink Eye Relief sterile eye drops, a homeopathic ophthalmic product manufactured by AMMAN PHARMACEUTICAL INDUSTRIES, are being recalled due to lack of assurance of sterility.
The FDA has determined that the manufacturer cannot assure that the affected product meets sterility requirements. Sterile eye drops must be free from microbial contamination to be safe for use in the eye.
The product was distributed to direct accounts in Rhode Island and Colorado. The recalled product is available in 0.33 FL OZ (10 mL) bottles with the following lot numbers: IV001 (expiration 06/25), IV002 (expiration 11/24), and IV004 (expiration 01/25). The National Drug Code (NDC) is 17312-013-15, and approximately 293,400 units were distributed.
Consumers who have purchased this product should stop using it immediately and consult a healthcare provider if they have experienced any eye-related health problems.
The recalled product
- Product
- TRP Natural Eyes, Pink Eye Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-013-15.
- Manufacturer
- AMMAN PHARMACEUTICAL INDUSTRIES
- Category
- Drug — Eye Drops / Ophthalmic
- Hazard
- lack-of-sterility
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot: IV001 EXP:06/25
- Lot:IV002 EXP: 11/24
- Lot:IV004 EXP:01/25
Distribution
Distributed in 2 states:
- CO
- RI
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27